Pancreatic Cancer: Why Early Detection Remains the Biggest Challenge
Surgery currently offers the only potential cure for pancreatic cancer. However, it’s often not an option at the time of diagnosis for most patients. This is due to late diagnoses, the complex location of the pancreas, and the aggressive nature of the disease, explains Dr. Brice Chanez, a medical oncologist at the Institut Paoli-Calmettes.
The Silent Threat: Why Pancreatic Cancer is Often Diagnosed Late
Pancreatic cancer often develops without clear early warning signs. “Diagnosis is late because there aren’t really specific symptoms,” says Dr. Chanez. Unlike some other cancers, there’s no immediately obvious symptom to trigger concern. “You can palpate a breast, you can have blood in your stool with colon cancer, but you can’t feel your pancreas.”
Initial symptoms are frequently non-specific, such as unusual fatigue, loss of appetite, and gradual weight loss. Patients may continue to eat normal quantities of food while still losing weight. These symptoms can develop over several months before any investigations are undertaken.
More Evocative Signs, But Often at a Later Stage
More specific signs do exist, but typically appear at a more advanced stage. These include jaundice (icterus), caused by a blockage of the bile duct by the tumor, particularly in tumors located in the head of the pancreas. This results in yellowing of the skin, dark urine, and pale stools. Epigastric pain, radiating to the back, can also indicate pancreatic involvement.
However, by the time these symptoms appear, the tumor is often already large, and potentially inoperable. The disease is also invasive, frequently metastasizing to the liver or peritoneum, causing pain, abdominal fluid accumulation, and rapid deterioration.
Surgical Challenges: Anatomy and Complexity
Even in the absence of metastasis, surgery isn’t always feasible. “The pancreas is a small organ, behind the stomach, next to the bile ducts, and most importantly in contact with major blood vessels essential for the digestive tract and liver,” explains Dr. Chanez.
The principle in cancer surgery is to remove all affected tissue, plus a margin of healthy tissue. However, in pancreatic cancer, these margins often involve major blood vessels. “These vessels cannot be sacrificed; they cannot be cut.”
Partial surgery is ineffective. Removing 90% of the tumor while leaving invaded tissue serves no purpose. The surgery itself is extensive, lasting an average of eight hours, with a mortality rate of 2-4% and a morbidity rate of around 30%. Recovery is lengthy, potentially delaying further treatments.
Treatment Options When Surgery Isn’t Immediately Possible
At diagnosis, approximately 50% of patients have non-metastatic disease, but only 20% are immediately operable. Another 30% are considered locally advanced. For these patients, neoadjuvant chemotherapy – chemotherapy given before surgery – may be an option to attempt to reduce the tumor size and reassess surgical feasibility.
When the disease has metastasized, surgery is not indicated. Radiotherapy has shown limited success. Targeted therapies and immunotherapy have not demonstrated significant benefit to date.
The Critical Need for Earlier Detection
Dr. Chanez emphasizes that earlier diagnosis is the primary goal. “The real path is to discover tumors much earlier.” Currently, there is no organized screening program for the general population. However, individuals with a family history – two or more cases among first-degree relatives – may benefit from specific surveillance.
With approximately 14,000 latest cases annually in France and nearly 12,000-13,000 deaths, pancreatic cancer remains one of the most deadly. “It’s not a frequent cancer, but it’s a cancer that kills many,” concludes Dr. Chanez.
Frequently Asked Questions
- What are the first signs of pancreatic cancer?
- The first signs are often non-specific, including fatigue, loss of appetite, and unexplained weight loss.
- Is surgery always an option for pancreatic cancer?
- No, surgery is only possible in a minority of cases, typically when the cancer is diagnosed early and hasn’t spread.
- What happens if surgery isn’t possible?
- Chemotherapy may be used to try and shrink the tumor, or other treatments like radiotherapy may be considered, although their effectiveness is limited.
- Is there a screening test for pancreatic cancer?
- No, there is currently no organized screening program for the general population, but those with a strong family history may be monitored.
Explore more articles on cancer research and treatment. Share your thoughts in the comments below.
